<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39292743</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>121</Volume><Issue>39</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>24</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Lipin1 depletion coordinates neuronal signaling pathways to promote motor and sensory axon regeneration after spinal cord injury.</ArticleTitle><Pagination><StartPage>e2404395121</StartPage><MedlinePgn>e2404395121</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2404395121</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.2404395121</ELocationID><Abstract><AbstractText>Adult central nervous system (CNS) neurons down-regulate growth programs after injury, leading to persistent regeneration failure. Coordinated lipids metabolism is required to synthesize membrane components during axon regeneration. However, lipids also function as cell signaling molecules. Whether lipid signaling contributes to axon regeneration remains unclear. In this study, we showed that lipin1 orchestrates mechanistic target of rapamycin (mTOR) and STAT3 signaling pathways to determine axon regeneration. We established an mTOR-lipin1-phosphatidic acid/lysophosphatidic acid-mTOR loop that acts as a positive feedback inhibitory signaling, contributing to the persistent suppression of CNS axon regeneration following injury. In addition, lipin1 knockdown (KD) enhances corticospinal tract (CST) sprouting after unilateral pyramidotomy and promotes CST regeneration following complete spinal cord injury (SCI). Furthermore, lipin1 KD enhances sensory axon regeneration after SCI. Overall, our research reveals that lipin1 functions as a central regulator to coordinate mTOR and STAT3 signaling pathways in the CNS neurons and highlights the potential of lipin1 as a promising therapeutic target for promoting the regeneration of motor and sensory axons after SCI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>Weitao</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-3504-011X</Identifier><AffiliationInfo><Affiliation>Biomedical Research Institute, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen 518036, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wu</LastName><ForeName>Junqiang</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9029-3016</Identifier><AffiliationInfo><Affiliation>Division of Life Science, State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Yang</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Life Science, State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, Hong Kong University of Science and Technology Shenzhen Research Institute, Shenzhen-Hong Kong Institute of Brain Science, Shenzhen, Guangdong 518057, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Suying</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Chemical Biology and Drug Discovery, Research Institute for Future Food, Research Centre for Chinese Medicine Innovation, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong Special Administrative Region, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong Special Administrative Region, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Chinese Medicine and Molecular Pharmacology (Incubation), Hong Kong Polytechnic University Shenzhen Research Institute, Shenzhen 518057, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shenzhen Key Laboratory of Food Biological Safety Control, Hong Kong Polytechnic University Shenzhen Research Institute, Shenzhen 518057, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhewei</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0003-1802-8979</Identifier><AffiliationInfo><Affiliation>Division of Life Science, State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>An</LastName><ForeName>Yongyan</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-3374-2046</Identifier><AffiliationInfo><Affiliation>Division of Life Science, State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xuejie</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Division of Life Science, State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Jiaming</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Life Science, State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jiahui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Life Science, State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, Hong Kong University of Science and Technology Shenzhen Research Institute, Shenzhen-Hong Kong Institute of Brain Science, Shenzhen, Guangdong 518057, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>Yangyang</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-0823-6574</Identifier><AffiliationInfo><Affiliation>Division of Life Science, State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, Hong Kong University of Science and Technology Shenzhen Research Institute, Shenzhen-Hong Kong Institute of Brain Science, Shenzhen, Guangdong 518057, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Xue</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0003-0515-1847</Identifier><AffiliationInfo><Affiliation>Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xin</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-8820-5128</Identifier><AffiliationInfo><Affiliation>Division of Life Science, State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yiren</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Life Science, State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ip</LastName><ForeName>Jacque Pak Kan</ForeName><Initials>JPK</Initials><Identifier Source="ORCID">0000-0003-4545-8261</Identifier><AffiliationInfo><Affiliation>School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Amy K Y</ForeName><Initials>AKY</Initials><AffiliationInfo><Affiliation>Division of Life Science, State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, Hong Kong University of Science and Technology Shenzhen Research Institute, Shenzhen-Hong Kong Institute of Brain Science, Shenzhen, Guangdong 518057, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ip</LastName><ForeName>Nancy Y</ForeName><Initials>NY</Initials><Identifier Source="ORCID">0000-0002-2763-8907</Identifier><AffiliationInfo><Affiliation>Division of Life Science, State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, Hong Kong University of Science and Technology Shenzhen Research Institute, Shenzhen-Hong Kong Institute of Brain Science, Shenzhen, Guangdong 518057, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Zhongping</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0003-3555-9632</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Chemical Biology and Drug Discovery, Research Institute for Future Food, Research Centre for Chinese Medicine Innovation, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong Special Administrative Region, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong Special Administrative Region, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Chinese Medicine and Molecular Pharmacology (Incubation), Hong Kong Polytechnic University Shenzhen Research Institute, Shenzhen 518057, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shenzhen Key Laboratory of Food Biological Safety Control, Hong Kong Polytechnic University Shenzhen Research Institute, Shenzhen 518057, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Kai</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-9351-1640</Identifier><AffiliationInfo><Affiliation>Biomedical Research Institute, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen 518036, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Life Science, State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, Hong Kong University of Science and Technology Shenzhen Research Institute, Shenzhen-Hong Kong Institute of Brain Science, Shenzhen, Guangdong 518057, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemical and Biological Engineering, The Hong Kong University of Science and Technology, Hong Kong, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AoE/M-604/16 C6034-21G T13-602/21 N 16102519</GrantID><Agency>Hong Kong Research Grant Council</Agency><Country /></Grant><Grant><GrantID>ITCPD/17-9</GrantID><Agency>Innovation and Technology Commission (ITC)</Agency><Country /></Grant><Grant><GrantID>06173946</GrantID><Agency>Hong Kong Center for Neurodegenerative Diseases InnoHK of Hong Kong SAR, Health and Medical Reasearch Fund</Agency><Country /></Grant><Grant><GrantID>82171384</GrantID><Agency>MOST | National Natural Science Foundation of China (NSFC)</Agency><Country /></Grant><Grant><GrantID>20200730009</GrantID><Agency>Guangzhou Key Projects of Brain Science and Brain-Like Intelligence Technology</Agency><Country /></Grant><Grant><GrantID>2019SHIBS0001</GrantID><Agency>Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions</Agency><Country /></Grant><Grant><GrantID>no</GrantID><Agency>Nan Fung Life Sciences (NFLS)</Agency><Country /></Grant><Grant><GrantID>2021A1515010856</GrantID><Agency>GDSTC | Natural Science Foundation of Guangdong Province ()</Agency><Country /></Grant><Grant><GrantID>15304020 R5013-19 R4005-18 and C4002-20WF</GrantID><Agency>Hong Kong Research Grant Council</Agency><Country /></Grant><Grant><GrantID>24117220</GrantID><Agency>Hong Kong Research Grant Council</Agency><Country /></Grant><Grant><GrantID>14117221</GrantID><Agency>Hong Kong Research Grant Council</Agency><Country /></Grant><Grant><GrantID>AoE/M-604/16</GrantID><Agency>Hong Kong Research Grant Council</Agency><Country /></Grant><Grant><GrantID>ITCPD/17-9</GrantID><Agency>Innovation and Technology Commission (ITC)</Agency><Country /></Grant><Grant><GrantID>06173946</GrantID><Agency>Hong Kong Center for Neurodegenerative Diseases InnoHK of Hong Kong SAR, Health and Medical Reasearch Fund</Agency><Country /></Grant><Grant><GrantID>20200730009</GrantID><Agency>Guangzhou Key Projects of Brain Science and Brain-Like Intelligence Technology</Agency><Country /></Grant><Grant><GrantID>2019SHIBS0001</GrantID><Agency>Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050796">STAT3 Transcription Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D058570">TOR Serine-Threonine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.3.4</RegistryNumber><NameOfSubstance UI="D010711">Phosphatidate Phosphatase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.3.4</RegistryNumber><NameOfSubstance UI="C418978">Lpin1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010712">Phosphatidic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.1.1</RegistryNumber><NameOfSubstance UI="C546843">mTOR protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494087">Stat3 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D013119" MajorTopicYN="Y">Spinal Cord Injuries</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001369" MajorTopicYN="Y">Axons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009416" MajorTopicYN="Y">Nerve Regeneration</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050796" MajorTopicYN="Y">STAT3 Transcription Factor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058570" MajorTopicYN="Y">TOR Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010711" MajorTopicYN="Y">Phosphatidate Phosphatase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="Y">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010712" MajorTopicYN="N">Phosphatidic Acids</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011984" MajorTopicYN="N">Sensory Receptor Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011712" MajorTopicYN="N">Pyramidal Tracts</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">axon regeneration</Keyword><Keyword MajorTopicYN="N">lipid metabolism</Keyword><Keyword MajorTopicYN="N">lipid signaling</Keyword><Keyword MajorTopicYN="N">lipin1</Keyword><Keyword MajorTopicYN="N">spinal cord injury</Keyword></KeywordList><CoiStatement>Competing interests statement:The authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>18</Day><Hour>18</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>18</Day><Hour>18</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>18</Day><Hour>13</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39292743</ArticleId><ArticleId IdType="pmc">PMC11441493</ArticleId><ArticleId IdType="doi">10.1073/pnas.2404395121</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bradke F., Fawcett J. W., Spira M. E., Assembly of a new growth cone after axotomy: The precursor to axon regeneration. Nat. Rev. Neurosci. 13, 183–193 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22334213</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfenninger K. H., Plasma membrane expansion: A neuron’s Herculean task. Nat. Rev. Neurosci. 10, 251–261 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19259102</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance J. E., Campenot R. B., Vance D. E., The synthesis and transport of lipids for axonal growth and nerve regeneration. Biochim. Biophys. Acta 1486, 84–96 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10856715</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C., et al. , Rewiring neuronal glycerolipid metabolism determines the extent of axon regeneration. Neuron 105, 276–292.e5 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6975164</ArticleId><ArticleId IdType="pubmed">31786011</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos A. L., Preta G., Lipids in the cell: Organisation regulates function. Cell. Mol. Life Sci. 75, 1909–1927 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11105414</ArticleId><ArticleId IdType="pubmed">29427074</ArticleId></ArticleIdList></Reference><Reference><Citation>Storck E. M., Özbalci C., Eggert U. S., Lipid cell biology: A focus on lipids in cell division. Annu. Rev. Biochem. 87, 839–869 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29494237</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunshine H., Iruela-Arispe M. L., Membrane lipids and cell signaling. Curr. Opin. Lipidol. 28, 408–413 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5776726</ArticleId><ArticleId IdType="pubmed">28692598</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutkewitte A. J., Finck B. N., Regulation of signaling and metabolism by lipin-mediated phosphatidic acid phosphohydrolase activity. Biomolecules 10, 1386 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7600782</ArticleId><ArticleId IdType="pubmed">33003344</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammar M.-R., Kassas N., Bader M.-F., Vitale N., Phosphatidic acid in neuronal development: A node for membrane and cytoskeleton rearrangements. Biochimie 107, 51–57 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25111738</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance J. E., Vance D. E., Phospholipid biosynthesis in mammalian cells. Biochem. Cell Biol. 82, 113–128 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15052332</ArticleId></ArticleIdList></Reference><Reference><Citation>Frias M. A., Hatipoglu A., Foster D. A., Regulation of mTOR by phosphatidic acid. Trends Endocrinol. Metabol. 34, 170–180 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9957947</ArticleId><ArticleId IdType="pubmed">36732094</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Y., Vilella-Bach M., Bachmann R., Flanigan A., Chen J., Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 294, 1942–1945 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11729323</ArticleId></ArticleIdList></Reference><Reference><Citation>Yung Y. C., Stoddard N. C., Mirendil H., Chun J., Lysophosphatidic acid signaling in the nervous system. Neuron 85, 669–682 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4400838</ArticleId><ArticleId IdType="pubmed">25695267</ArticleId></ArticleIdList></Reference><Reference><Citation>Geraldo L. H. M., et al. , Role of lysophosphatidic acid and its receptors in health and disease: Novel therapeutic strategies. Signal Transduct. Target Ther. 6, 45 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7851145</ArticleId><ArticleId IdType="pubmed">33526777</ArticleId></ArticleIdList></Reference><Reference><Citation>Belin S., et al. , Injury-induced decline of intrinsic regenerative ability revealed by quantitative proteomics. Neuron 86, 1000–1014 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4551425</ArticleId><ArticleId IdType="pubmed">25937169</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., et al. , Driving axon regeneration by orchestrating neuronal and non-neuronal innate immune responses via the IFNγ-cGAS-STING axis. Neuron 111, 236–255 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9851977</ArticleId><ArticleId IdType="pubmed">36370710</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X.-W., et al. , Lin28 signaling supports mammalian PNS and CNS axon regeneration. Cell Rep. 24, 2540–2552.e6 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6173831</ArticleId><ArticleId IdType="pubmed">30184489</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandran V., et al. , A systems-level analysis of the peripheral nerve intrinsic axonal growth program. Neuron 89, 956–970 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4790095</ArticleId><ArticleId IdType="pubmed">26898779</ArticleId></ArticleIdList></Reference><Reference><Citation>Alber S., et al. , PTBP1 regulates injury responses and sensory pathways in adult peripheral neurons. Sci. Adv. 9, eadi0286 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10381954</ArticleId><ArticleId IdType="pubmed">37506203</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H. J., et al. , Deep scRNA sequencing reveals a broadly applicable Regeneration Classifier and implicates antioxidant response in corticospinal axon regeneration. Neuron 111, 3953–3969.e5 (2023), 10.1016/j.neuron.2023.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2023.09.019</ArticleId><ArticleId IdType="pmc">PMC10843387</ArticleId><ArticleId IdType="pubmed">37848024</ArticleId></ArticleIdList></Reference><Reference><Citation>Poplawski G. H. D., et al. , Injured adult neurons regress to an embryonic transcriptional growth state. Nature 581, 77–82 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32376949</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Y., et al. , Chronic stress hinders sensory axon regeneration via impairing mitochondrial cristae and OXPHOS. Sci. Adv. 9, eadh0183 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10558127</ArticleId><ArticleId IdType="pubmed">37801508</ArticleId></ArticleIdList></Reference><Reference><Citation>Serger E., et al. , The gut metabolite indole-3 propionate promotes nerve regeneration and repair. Nature 607, 585–592 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35732737</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L., et al. , Reversible CD8 T cell–neuron cross-talk causes aging-dependent neuronal regenerative decline. Science 376, eabd5926 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35549409</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K., et al. , PTEN deletion enhances the regenerative ability of adult corticospinal neurons. Nat. Neurosci. 13, 1075–1081 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2928871</ArticleId><ArticleId IdType="pubmed">20694004</ArticleId></ArticleIdList></Reference><Reference><Citation>Park K. K., et al. , Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 322, 963–966 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2652400</ArticleId><ArticleId IdType="pubmed">18988856</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., et al. , Promoting axon regeneration in the adult CNS by modulation of the melanopsin/GPCR signaling. Proc. Natl. Acad. Sci. U.S.A. 113, 1937–1942 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4763730</ArticleId><ArticleId IdType="pubmed">26831088</ArticleId></ArticleIdList></Reference><Reference><Citation>Du K., et al. , Pten deletion promotes regrowth of corticospinal tract axons 1 year after spinal cord injury. J. Neurosci. 35, 9754–9763 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6605149</ArticleId><ArticleId IdType="pubmed">26134657</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y., et al. , Regeneration of Drosophila sensory neuron axons and dendrites is regulated by the Akt pathway involving Pten and microRNA bantam. Genes Dev. 26, 1612–1625 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3404388</ArticleId><ArticleId IdType="pubmed">22759636</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne A. B., et al. , Insulin/IGF1 signaling inhibits age-dependent axon regeneration. Neuron 81, 561–573 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3924874</ArticleId><ArticleId IdType="pubmed">24440228</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D., Yu Y., Schachner M., Ptena, but not Ptenb, reduces regeneration after spinal cord injury in adult zebrafish. Exp. Neurol. 261, 196–205 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24929056</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhulyn O., et al. , Evolutionarily divergent mTOR remodels translatome for tissue regeneration. Nature 620, 163–171 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11181899</ArticleId><ArticleId IdType="pubmed">37495694</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaniv S. P., Issman-Zecharya N., Oren-Suissa M., Podbilewicz B., Schuldiner O., Axon regrowth during development and regeneration following injury share molecular mechanisms. Curr. Biol. 22, 1774–1782 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22921367</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu J., Conditioning injury-induced spinal axon regeneration requires signal transducer and activator of transcription 3 activation. J. Neurosci. 25, 1645–1653 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6725934</ArticleId><ArticleId IdType="pubmed">15716400</ArticleId></ArticleIdList></Reference><Reference><Citation>Bareyre F. M., et al. , In vivo imaging reveals a phase-specific role of STAT3 during central and peripheral nervous system axon regeneration. Proc. Natl. Acad. Sci. U.S.A. 108, 6282–6287 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3076857</ArticleId><ArticleId IdType="pubmed">21447717</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith P. D., et al. , SOCS3 deletion promotes optic nerve regeneration in vivo. Neuron 64, 617–623 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2796263</ArticleId><ArticleId IdType="pubmed">20005819</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo X., et al. , Enhanced transcriptional activity and mitochondrial localization of STAT3 co-induce axon regrowth in the adult central nervous system. Cell Rep. 15, 398–410 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4833545</ArticleId><ArticleId IdType="pubmed">27050520</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta S. T., Luo X., Park K. K., Bixby J. L., Lemmon V. P., Hyperactivated Stat3 boosts axon regeneration in the CNS. Exp. Neurol. 280, 115–120 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4888791</ArticleId><ArticleId IdType="pubmed">27060489</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun F., et al. , Sustained axon regeneration induced by co-deletion of PTEN and SOCS3. Nature 480, 372–375 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240702</ArticleId><ArticleId IdType="pubmed">22056987</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin D., et al. , Restoration of skilled locomotion by sprouting corticospinal axons induced by co-deletion of PTEN and SOCS3. Nat. Commun. 6, 8074 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4662086</ArticleId><ArticleId IdType="pubmed">26598325</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackmore M. G., et al. , Krüppel-like factor 7 engineered for transcriptional activation promotes axon regeneration in the adult corticospinal tract. Proc. Natl. Acad. Sci. U.S.A. 109, 7517–7522 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3358880</ArticleId><ArticleId IdType="pubmed">22529377</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Reynolds A., Kirry A., Nienhaus C., Blackmore M. G., Overexpression of Sox11 promotes corticospinal tract regeneration after spinal injury while interfering with functional recovery. J. Neurosci. 35, 3139–3145 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4331631</ArticleId><ArticleId IdType="pubmed">25698749</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohtake Y., et al. , Promoting axon regeneration in adult CNS by targeting liver kinase B1. Mol. Therapy 27, 102–117 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6319317</ArticleId><ArticleId IdType="pubmed">30509565</ArticleId></ArticleIdList></Reference><Reference><Citation>Nathan F. M., et al. , Upregulating Lin28a promotes axon regeneration in adult mice with optic nerve and spinal cord injury. Mol. Therapy 28, 1902–1917 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7403348</ArticleId><ArticleId IdType="pubmed">32353321</ArticleId></ArticleIdList></Reference><Reference><Citation>Boato F., et al. , Activation of MAP2K signaling by genetic engineering or HF-rTMS promotes corticospinal axon sprouting and functional regeneration. Sci. Transl. Med. 15, eabq6885 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36599003</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W., et al. , Rapamycin-resistant mTOR activity is required for sensory axon regeneration induced by a conditioning lesion. eNeuro 3, ENEURO.0358-16.2016 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5234127</ArticleId><ArticleId IdType="pubmed">28101526</ArticleId></ArticleIdList></Reference><Reference><Citation>Linqing M., et al. , mTORC1 is necessary but mTORC2 and GSK3β are inhibitory for AKT3-induced axon regeneration in the central nervous system. Elife 5, e14908 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4841781</ArticleId><ArticleId IdType="pubmed">27026523</ArticleId></ArticleIdList></Reference><Reference><Citation>Laplante M., Sabatini D. M., mTOR signaling in growth control and disease. Cell 149, 274–293 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3331679</ArticleId><ArticleId IdType="pubmed">22500797</ArticleId></ArticleIdList></Reference><Reference><Citation>Kok B. P. C., Kienesberger P. C., Dyck J. R. B., Brindley D. N., Relationship of glucose and oleate metabolism to cardiac function in lipin-1 deficient (fld) mice. J. Lipid Res. 53, 105–118 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243467</ArticleId><ArticleId IdType="pubmed">22058427</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon M.-S., Sun Y., Arauz E., Jiang Y., Chen J., Phosphatidic acid activates mammalian target of rapamycin complex 1 (mTORC1) kinase by displacing FK506 binding protein 38 (FKBP38) and exerting an allosteric effect. J. Biol. Chem. 286, 29568–29574 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3190997</ArticleId><ArticleId IdType="pubmed">21737445</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellery J., et al. , Identification of compounds acting as negative allosteric modulators of the LPA1 receptor. Eur. J. Pharmacol. 833, 8–15 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29807028</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohta H., et al. , Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors. Mol. Pharmacol. 64, 994–1005 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">14500756</ArticleId></ArticleIdList></Reference><Reference><Citation>Swaney J. S., et al. , Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist. J. Pharmacol. Exp. Ther. 336, 693–700 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21159750</ArticleId></ArticleIdList></Reference><Reference><Citation>Morstein J., et al. , Optical control of lysophosphatidic acid signaling. J. Am. Chem. Soc. 142, 10612–10616 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7920854</ArticleId><ArticleId IdType="pubmed">32469525</ArticleId></ArticleIdList></Reference><Reference><Citation>Tee A. R., Manning B. D., Roux P. P., Cantley L. C., Blenis J., Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr. Biol. 13, 1259–1268 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12906785</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernstein D. R., Stelzner D. J., Plasticity of the corticospinal tract following midthoracic spinal injury in the postnatal rat. J. Comp. Neurol. 221, 382–400 (1983).</Citation><ArticleIdList><ArticleId IdType="pubmed">6662981</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., et al. , Microglia-organized scar-free spinal cord repair in neonatal mice. Nature 587, 613–618 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7704837</ArticleId><ArticleId IdType="pubmed">33029008</ArticleId></ArticleIdList></Reference><Reference><Citation>Zukor K., et al. , Short hairpin RNA against PTEN enhances regenerative growth of corticospinal tract axons after spinal cord injury. J. Neurosci. 33, 15350–15361 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3782617</ArticleId><ArticleId IdType="pubmed">24068802</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris T. E., Finck B. N., Dual function lipin proteins and glycerolipid metabolism. Trends Endocrinol. Metabol. 22, 226–233 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3118913</ArticleId><ArticleId IdType="pubmed">21470873</ArticleId></ArticleIdList></Reference><Reference><Citation>Reue K., Zhang P., The lipin protein family: Dual roles in lipid biosynthesis and gene expression. FEBS Lett. 582, 90–96 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2848953</ArticleId><ArticleId IdType="pubmed">18023282</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson T. R., et al. , mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell 146, 408–420 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3336367</ArticleId><ArticleId IdType="pubmed">21816276</ArticleId></ArticleIdList></Reference><Reference><Citation>Yung Y. C., Stoddard N. C., Chun J., LPA receptor signaling: Pharmacology, physiology, and pathophysiology. J. Lipid Res. 55, 1192–1214 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4076099</ArticleId><ArticleId IdType="pubmed">24643338</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., et al. , Deconstruction of corticospinal circuits for goal-directed motor skills. Cell 171, 440–455.e14 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5679421</ArticleId><ArticleId IdType="pubmed">28942925</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng B., Tuszynski M. H., Regulation of axonal regeneration after mammalian spinal cord injury. Nat. Rev. Mol. Cell Biol. 24, 396–413 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36604586</ArticleId></ArticleIdList></Reference><Reference><Citation>Squair J. W., et al. , Recovery of walking after paralysis by regenerating characterized neurons to their natural target region. Science 381, 1338–1345 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37733871</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>